Phase 2
N=3
Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)
Post Traumatic Stress Disorder
Bottom Line
View on ClinicalTrials.gov: NCT03375294 ↗Enrolled (actual)
3
Serious AEs
0.0%
Results posted
Jul 2020
Primary outcome: Primary: Number of Patients Who Met and Exceeded Response Criteria of Clinician Administered PTSD Scale for DSM-5 (CAPS-5) — 2 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Nitrous Oxide (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Stanford University
- Primary completion
- Jul 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients Who Met and Exceeded Response Criteria of Clinician Administered PTSD Scale for DSM-5 (CAPS-5) |
2 | — |
Summary
The purpose of this study is to understand nitrous oxide effects in post traumatic stress disorder (PTSD)
Eligibility Criteria
Inclusion Criteria
- age 18-80
- Veterans of the United States Uniformed Services
- primary diagnosis of PTSD
- sufficient severity of PTSD symptoms
- fluency in English
- capacity to provide informed consent
Exclusion Criteria
- psychiatric or medical conditions that make participation unsafe
- pregnant or nursing females
- allergy to nitrous oxide
Data sourced from ClinicalTrials.gov (NCT03375294). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.